174 related articles for article (PubMed ID: 18753704)
1. Anti-atherogenic actions of high-density lipoprotein through sphingosine 1-phosphate receptors and scavenger receptor class B type I.
Okajima F; Sato K; Kimura T
Endocr J; 2009; 56(3):317-34. PubMed ID: 18753704
[TBL] [Abstract][Full Text] [Related]
2. ApoA-I/SR-BI modulates S1P/S1PR2-mediated inflammation through the PI3K/Akt signaling pathway in HUVECs.
Ren K; Lu YJ; Mo ZC; -Liu X; Tang ZL; Jiang Y; Peng XS; Li L; Zhang QH; Yi GH
J Physiol Biochem; 2017 May; 73(2):287-296. PubMed ID: 28181168
[TBL] [Abstract][Full Text] [Related]
3. High-Density Lipoprotein-Associated Apolipoprotein M Limits Endothelial Inflammation by Delivering Sphingosine-1-Phosphate to the Sphingosine-1-Phosphate Receptor 1.
Ruiz M; Frej C; Holmér A; Guo LJ; Tran S; Dahlbäck B
Arterioscler Thromb Vasc Biol; 2017 Jan; 37(1):118-129. PubMed ID: 27879252
[TBL] [Abstract][Full Text] [Related]
4. Role of scavenger receptor class B type I and sphingosine 1-phosphate receptors in high density lipoprotein-induced inhibition of adhesion molecule expression in endothelial cells.
Kimura T; Tomura H; Mogi C; Kuwabara A; Damirin A; Ishizuka T; Sekiguchi A; Ishiwara M; Im DS; Sato K; Murakami M; Okajima F
J Biol Chem; 2006 Dec; 281(49):37457-67. PubMed ID: 17046831
[TBL] [Abstract][Full Text] [Related]
5. Induction of scavenger receptor class B type I is critical for simvastatin enhancement of high-density lipoprotein-induced anti-inflammatory actions in endothelial cells.
Kimura T; Mogi C; Tomura H; Kuwabara A; Im DS; Sato K; Kurose H; Murakami M; Okajima F
J Immunol; 2008 Nov; 181(10):7332-40. PubMed ID: 18981156
[TBL] [Abstract][Full Text] [Related]
6. Signal transduction by HDL: agonists, receptors, and signaling cascades.
Nofer JR
Handb Exp Pharmacol; 2015; 224():229-56. PubMed ID: 25522990
[TBL] [Abstract][Full Text] [Related]
7. [Measurement of sphingosine 1-phosphate as a biomarker of atherosclerosis].
Kimura T; Okajima F; Murakami M
Rinsho Byori; 2007 Apr; 55(4):358-62. PubMed ID: 17511266
[TBL] [Abstract][Full Text] [Related]
8. S1P in HDL promotes interaction between SR-BI and S1PR1 and activates S1PR1-mediated biological functions: calcium flux and S1PR1 internalization.
Lee MH; Appleton KM; El-Shewy HM; Sorci-Thomas MG; Thomas MJ; Lopes-Virella MF; Luttrell LM; Hammad SM; Klein RL
J Lipid Res; 2017 Feb; 58(2):325-338. PubMed ID: 27881715
[TBL] [Abstract][Full Text] [Related]
9. ApoA-I induces S1P release from endothelial cells through ABCA1 and SR-BI in a positive feedback manner.
Liu X; Ren K; Suo R; Xiong SL; Zhang QH; Mo ZC; Tang ZL; Jiang Y; Peng XS; Yi GH
J Physiol Biochem; 2016 Dec; 72(4):657-667. PubMed ID: 27377933
[TBL] [Abstract][Full Text] [Related]
10. Atheroprotective role of high-density lipoprotein (HDL)-associated sphingosine-1-phosphate (S1P).
Potì F; Simoni M; Nofer JR
Cardiovasc Res; 2014 Aug; 103(3):395-404. PubMed ID: 24891400
[TBL] [Abstract][Full Text] [Related]
11. HDL-associated ApoM is anti-apoptotic by delivering sphingosine 1-phosphate to S1P1 & S1P3 receptors on vascular endothelium.
Ruiz M; Okada H; Dahlbäck B
Lipids Health Dis; 2017 Feb; 16(1):36. PubMed ID: 28179022
[TBL] [Abstract][Full Text] [Related]
12. [The role of apolipoprotein M and sphingosine 1-phosphate axis in the prevention of atherosclerosis].
Nádró B; Juhász L; Szentpéteri A; Páll D; Paragh G; Harangi M
Orv Hetil; 2018 Feb; 159(5):168-175. PubMed ID: 29376427
[TBL] [Abstract][Full Text] [Related]
13. Sphingosine-1-phosphate: A bioactive lipid that confers high-density lipoprotein with vasculoprotection mediated by nitric oxide and prostacyclin.
Rodríguez C; González-Díez M; Badimon L; Martínez-González J
Thromb Haemost; 2009 Apr; 101(4):665-73. PubMed ID: 19350109
[TBL] [Abstract][Full Text] [Related]
14. Selective attenuation of Toll-like receptor 2 signalling may explain the atheroprotective effect of sphingosine 1-phosphate.
Dueñas AI; Aceves M; Fernández-Pisonero I; Gómez C; Orduña A; Crespo MS; García-Rodríguez C
Cardiovasc Res; 2008 Aug; 79(3):537-44. PubMed ID: 18411230
[TBL] [Abstract][Full Text] [Related]
15. Sphingosine-1-phosphate: metabolism, transport, atheroprotection and effect of statin treatment.
Therond P; Chapman MJ
Curr Opin Lipidol; 2022 Jun; 33(3):199-207. PubMed ID: 35695616
[TBL] [Abstract][Full Text] [Related]
16. Relevance of sphingolipids in the pleiotropic protective effects of high-density lipoproteins.
Tölle M; Schuchardt M; van der Giet M
Curr Pharm Des; 2010 May; 16(13):1468-79. PubMed ID: 20196741
[TBL] [Abstract][Full Text] [Related]
17. Sphingosine 1-phosphate (S1P) carrier-dependent regulation of endothelial barrier: high density lipoprotein (HDL)-S1P prolongs endothelial barrier enhancement as compared with albumin-S1P via effects on levels, trafficking, and signaling of S1P1.
Wilkerson BA; Grass GD; Wing SB; Argraves WS; Argraves KM
J Biol Chem; 2012 Dec; 287(53):44645-53. PubMed ID: 23135269
[TBL] [Abstract][Full Text] [Related]
18. High-density lipoprotein stimulates endothelial cell migration and survival through sphingosine 1-phosphate and its receptors.
Kimura T; Sato K; Malchinkhuu E; Tomura H; Tamama K; Kuwabara A; Murakami M; Okajima F
Arterioscler Thromb Vasc Biol; 2003 Jul; 23(7):1283-8. PubMed ID: 12775579
[TBL] [Abstract][Full Text] [Related]
19. High density lipoprotein stimulated migration of macrophages depends on the scavenger receptor class B, type I, PDZK1 and Akt1 and is blocked by sphingosine 1 phosphate receptor antagonists.
Al-Jarallah A; Chen X; González L; Trigatti BL
PLoS One; 2014; 9(9):e106487. PubMed ID: 25188469
[TBL] [Abstract][Full Text] [Related]
20. Role of sphingosine 1-phosphate in anti-atherogenic actions of high-density lipoprotein.
Sato K; Okajima F
World J Biol Chem; 2010 Nov; 1(11):327-37. PubMed ID: 21537467
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
